img

Global Antihelminthics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antihelminthics Market Research Report 2024

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.
According to Mr Accuracy reports’s new survey, global Antihelminthics market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antihelminthics market research.
Key manufacturers engaged in the Antihelminthics industry include Abbott, Novartis, ZEISS International, Johnson & Johnson, Sanofi, Merck & Co., GlaxoSmithKline, Astellas Pharma and Bayer, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Antihelminthics were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Antihelminthics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antihelminthics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott
Novartis
ZEISS International
Johnson & Johnson
Sanofi
Merck & Co.
GlaxoSmithKline
Astellas Pharma
Bayer
Mentis Pharma
Pfizer
Sanofi
ALLERGAN
AstraZeneca
Segment by Type
Benzimidazoles
Abamectin
Salicylanilides
Praziquantel
Other

Segment by Application


Schistosomiasis
Fasciolasis
Filariasis
Angiostrongylosis
Ascariasis
Giardiasis
Other

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Antihelminthics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Antihelminthics Market Overview
1.1 Product Overview and Scope of Antihelminthics
1.2 Antihelminthics Segment by Type
1.2.1 Global Antihelminthics Market Value Comparison by Type (2024-2034)
1.2.2 Benzimidazoles
1.2.3 Abamectin
1.2.4 Salicylanilides
1.2.5 Praziquantel
1.2.6 Other
1.3 Antihelminthics Segment by Application
1.3.1 Global Antihelminthics Market Value by Application: (2024-2034)
1.3.2 Schistosomiasis
1.3.3 Fasciolasis
1.3.4 Filariasis
1.3.5 Angiostrongylosis
1.3.6 Ascariasis
1.3.7 Giardiasis
1.3.8 Other
1.4 Global Antihelminthics Market Size Estimates and Forecasts
1.4.1 Global Antihelminthics Revenue 2018-2034
1.4.2 Global Antihelminthics Sales 2018-2034
1.4.3 Global Antihelminthics Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Antihelminthics Market Competition by Manufacturers
2.1 Global Antihelminthics Sales Market Share by Manufacturers (2018-2023)
2.2 Global Antihelminthics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Antihelminthics Average Price by Manufacturers (2018-2023)
2.4 Global Antihelminthics Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Antihelminthics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antihelminthics, Product Type & Application
2.7 Antihelminthics Market Competitive Situation and Trends
2.7.1 Antihelminthics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antihelminthics Players Market Share by Revenue
2.7.3 Global Antihelminthics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antihelminthics Retrospective Market Scenario by Region
3.1 Global Antihelminthics Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Antihelminthics Global Antihelminthics Sales by Region: 2018-2034
3.2.1 Global Antihelminthics Sales by Region: 2018-2023
3.2.2 Global Antihelminthics Sales by Region: 2024-2034
3.3 Global Antihelminthics Global Antihelminthics Revenue by Region: 2018-2034
3.3.1 Global Antihelminthics Revenue by Region: 2018-2023
3.3.2 Global Antihelminthics Revenue by Region: 2024-2034
3.4 North America Antihelminthics Market Facts & Figures by Country
3.4.1 North America Antihelminthics Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Antihelminthics Sales by Country (2018-2034)
3.4.3 North America Antihelminthics Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antihelminthics Market Facts & Figures by Country
3.5.1 Europe Antihelminthics Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Antihelminthics Sales by Country (2018-2034)
3.5.3 Europe Antihelminthics Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antihelminthics Market Facts & Figures by Country
3.6.1 Asia Pacific Antihelminthics Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Antihelminthics Sales by Country (2018-2034)
3.6.3 Asia Pacific Antihelminthics Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antihelminthics Market Facts & Figures by Country
3.7.1 Latin America Antihelminthics Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Antihelminthics Sales by Country (2018-2034)
3.7.3 Latin America Antihelminthics Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antihelminthics Market Facts & Figures by Country
3.8.1 Middle East and Africa Antihelminthics Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Antihelminthics Sales by Country (2018-2034)
3.8.3 Middle East and Africa Antihelminthics Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antihelminthics Sales by Type (2018-2034)
4.1.1 Global Antihelminthics Sales by Type (2018-2023)
4.1.2 Global Antihelminthics Sales by Type (2024-2034)
4.1.3 Global Antihelminthics Sales Market Share by Type (2018-2034)
4.2 Global Antihelminthics Revenue by Type (2018-2034)
4.2.1 Global Antihelminthics Revenue by Type (2018-2023)
4.2.2 Global Antihelminthics Revenue by Type (2024-2034)
4.2.3 Global Antihelminthics Revenue Market Share by Type (2018-2034)
4.3 Global Antihelminthics Price by Type (2018-2034)
5 Segment by Application
5.1 Global Antihelminthics Sales by Application (2018-2034)
5.1.1 Global Antihelminthics Sales by Application (2018-2023)
5.1.2 Global Antihelminthics Sales by Application (2024-2034)
5.1.3 Global Antihelminthics Sales Market Share by Application (2018-2034)
5.2 Global Antihelminthics Revenue by Application (2018-2034)
5.2.1 Global Antihelminthics Revenue by Application (2018-2023)
5.2.2 Global Antihelminthics Revenue by Application (2024-2034)
5.2.3 Global Antihelminthics Revenue Market Share by Application (2018-2034)
5.3 Global Antihelminthics Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Antihelminthics Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Antihelminthics Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 ZEISS International
6.3.1 ZEISS International Corporation Information
6.3.2 ZEISS International Description and Business Overview
6.3.3 ZEISS International Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 ZEISS International Antihelminthics Product Portfolio
6.3.5 ZEISS International Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson Antihelminthics Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sanofi Antihelminthics Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Merck & Co.
6.6.1 Merck & Co. Corporation Information
6.6.2 Merck & Co. Description and Business Overview
6.6.3 Merck & Co. Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck & Co. Antihelminthics Product Portfolio
6.6.5 Merck & Co. Recent Developments/Updates
6.7 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline Antihelminthics Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Astellas Pharma
6.8.1 Astellas Pharma Corporation Information
6.8.2 Astellas Pharma Description and Business Overview
6.8.3 Astellas Pharma Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Astellas Pharma Antihelminthics Product Portfolio
6.8.5 Astellas Pharma Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bayer Antihelminthics Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Mentis Pharma
6.10.1 Mentis Pharma Corporation Information
6.10.2 Mentis Pharma Description and Business Overview
6.10.3 Mentis Pharma Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Mentis Pharma Antihelminthics Product Portfolio
6.10.5 Mentis Pharma Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Antihelminthics Description and Business Overview
6.11.3 Pfizer Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Pfizer Antihelminthics Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Sanofi
6.12.1 Sanofi Corporation Information
6.12.2 Sanofi Antihelminthics Description and Business Overview
6.12.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Sanofi Antihelminthics Product Portfolio
6.12.5 Sanofi Recent Developments/Updates
6.13 ALLERGAN
6.13.1 ALLERGAN Corporation Information
6.13.2 ALLERGAN Antihelminthics Description and Business Overview
6.13.3 ALLERGAN Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 ALLERGAN Antihelminthics Product Portfolio
6.13.5 ALLERGAN Recent Developments/Updates
6.14 AstraZeneca
6.14.1 AstraZeneca Corporation Information
6.14.2 AstraZeneca Antihelminthics Description and Business Overview
6.14.3 AstraZeneca Antihelminthics Sales, Revenue and Gross Margin (2018-2023)
6.14.4 AstraZeneca Antihelminthics Product Portfolio
6.14.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antihelminthics Industry Chain Analysis
7.2 Antihelminthics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antihelminthics Production Mode & Process
7.4 Antihelminthics Sales and Marketing
7.4.1 Antihelminthics Sales Channels
7.4.2 Antihelminthics Distributors
7.5 Antihelminthics Customers
8 Antihelminthics Market Dynamics
8.1 Antihelminthics Industry Trends
8.2 Antihelminthics Market Drivers
8.3 Antihelminthics Market Challenges
8.4 Antihelminthics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Antihelminthics Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Antihelminthics Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Antihelminthics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Antihelminthics Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Antihelminthics Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Antihelminthics Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Antihelminthics Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Antihelminthics Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Antihelminthics, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Antihelminthics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antihelminthics, Product Type & Application
Table 12. Global Key Manufacturers of Antihelminthics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antihelminthics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihelminthics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antihelminthics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Antihelminthics Sales by Region (2018-2023) & (K Units)
Table 18. Global Antihelminthics Sales Market Share by Region (2018-2023)
Table 19. Global Antihelminthics Sales by Region (2024-2034) & (K Units)
Table 20. Global Antihelminthics Sales Market Share by Region (2024-2034)
Table 21. Global Antihelminthics Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Antihelminthics Revenue Market Share by Region (2018-2023)
Table 23. Global Antihelminthics Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Antihelminthics Revenue Market Share by Region (2024-2034)
Table 25. North America Antihelminthics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Antihelminthics Sales by Country (2018-2023) & (K Units)
Table 27. North America Antihelminthics Sales by Country (2024-2034) & (K Units)
Table 28. North America Antihelminthics Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Antihelminthics Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Antihelminthics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Antihelminthics Sales by Country (2018-2023) & (K Units)
Table 32. Europe Antihelminthics Sales by Country (2024-2034) & (K Units)
Table 33. Europe Antihelminthics Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Antihelminthics Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Antihelminthics Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Antihelminthics Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Antihelminthics Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Antihelminthics Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Antihelminthics Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Antihelminthics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Antihelminthics Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Antihelminthics Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Antihelminthics Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Antihelminthics Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Antihelminthics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Antihelminthics Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Antihelminthics Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Antihelminthics Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Antihelminthics Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Antihelminthics Sales (K Units) by Type (2018-2023)
Table 51. Global Antihelminthics Sales (K Units) by Type (2024-2034)
Table 52. Global Antihelminthics Sales Market Share by Type (2018-2023)
Table 53. Global Antihelminthics Sales Market Share by Type (2024-2034)
Table 54. Global Antihelminthics Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Antihelminthics Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Antihelminthics Revenue Market Share by Type (2018-2023)
Table 57. Global Antihelminthics Revenue Market Share by Type (2024-2034)
Table 58. Global Antihelminthics Price (USD/Unit) by Type (2018-2023)
Table 59. Global Antihelminthics Price (USD/Unit) by Type (2024-2034)
Table 60. Global Antihelminthics Sales (K Units) by Application (2018-2023)
Table 61. Global Antihelminthics Sales (K Units) by Application (2024-2034)
Table 62. Global Antihelminthics Sales Market Share by Application (2018-2023)
Table 63. Global Antihelminthics Sales Market Share by Application (2024-2034)
Table 64. Global Antihelminthics Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Antihelminthics Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Antihelminthics Revenue Market Share by Application (2018-2023)
Table 67. Global Antihelminthics Revenue Market Share by Application (2024-2034)
Table 68. Global Antihelminthics Price (USD/Unit) by Application (2018-2023)
Table 69. Global Antihelminthics Price (USD/Unit) by Application (2024-2034)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Abbott Antihelminthics Product
Table 74. Abbott Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Novartis Antihelminthics Product
Table 79. Novartis Recent Developments/Updates
Table 80. ZEISS International Corporation Information
Table 81. ZEISS International Description and Business Overview
Table 82. ZEISS International Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. ZEISS International Antihelminthics Product
Table 84. ZEISS International Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Johnson & Johnson Antihelminthics Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Sanofi Antihelminthics Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Merck & Co. Corporation Information
Table 96. Merck & Co. Description and Business Overview
Table 97. Merck & Co. Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Merck & Co. Antihelminthics Product
Table 99. Merck & Co. Recent Developments/Updates
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Business Overview
Table 102. GlaxoSmithKline Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. GlaxoSmithKline Antihelminthics Product
Table 104. GlaxoSmithKline Recent Developments/Updates
Table 105. Astellas Pharma Corporation Information
Table 106. Astellas Pharma Description and Business Overview
Table 107. Astellas Pharma Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Astellas Pharma Antihelminthics Product
Table 109. Astellas Pharma Recent Developments/Updates
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Bayer Antihelminthics Product
Table 114. Bayer Recent Developments/Updates
Table 115. Mentis Pharma Corporation Information
Table 116. Mentis Pharma Description and Business Overview
Table 117. Mentis Pharma Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Mentis Pharma Antihelminthics Product
Table 119. Mentis Pharma Recent Developments/Updates
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Pfizer Antihelminthics Product
Table 124. Pfizer Recent Developments/Updates
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Sanofi Antihelminthics Product
Table 129. Sanofi Recent Developments/Updates
Table 130. ALLERGAN Corporation Information
Table 131. ALLERGAN Description and Business Overview
Table 132. ALLERGAN Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. ALLERGAN Antihelminthics Product
Table 134. ALLERGAN Recent Developments/Updates
Table 135. AstraZeneca Corporation Information
Table 136. AstraZeneca Description and Business Overview
Table 137. AstraZeneca Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. AstraZeneca Antihelminthics Product
Table 139. AstraZeneca Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Antihelminthics Distributors List
Table 143. Antihelminthics Customers List
Table 144. Antihelminthics Market Trends
Table 145. Antihelminthics Market Drivers
Table 146. Antihelminthics Market Challenges
Table 147. Antihelminthics Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antihelminthics
Figure 2. Global Antihelminthics Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Antihelminthics Market Share by Type in 2024 & 2034
Figure 4. Benzimidazoles Product Picture
Figure 5. Abamectin Product Picture
Figure 6. Salicylanilides Product Picture
Figure 7. Praziquantel Product Picture
Figure 8. Other Product Picture
Figure 9. Global Antihelminthics Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Antihelminthics Market Share by Application in 2024 & 2034
Figure 11. Schistosomiasis
Figure 12. Fasciolasis
Figure 13. Filariasis
Figure 14. Angiostrongylosis
Figure 15. Ascariasis
Figure 16. Giardiasis
Figure 17. Other
Figure 18. Global Antihelminthics Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 19. Global Antihelminthics Market Size (2018-2034) & (US$ Million)
Figure 20. Global Antihelminthics Sales (2018-2034) & (K Units)
Figure 21. Global Antihelminthics Average Price (USD/Unit) & (2018-2034)
Figure 22. Antihelminthics Report Years Considered
Figure 23. Antihelminthics Sales Share by Manufacturers in 2024
Figure 24. Global Antihelminthics Revenue Share by Manufacturers in 2024
Figure 25. The Global 5 and 10 Largest Antihelminthics Players: Market Share by Revenue in 2024
Figure 26. Antihelminthics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 27. Global Antihelminthics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 28. North America Antihelminthics Sales Market Share by Country (2018-2034)
Figure 29. North America Antihelminthics Revenue Market Share by Country (2018-2034)
Figure 30. U.S. Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Canada Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Europe Antihelminthics Sales Market Share by Country (2018-2034)
Figure 33. Europe Antihelminthics Revenue Market Share by Country (2018-2034)
Figure 34. Germany Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. France Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. U.K. Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Italy Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Russia Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Asia Pacific Antihelminthics Sales Market Share by Region (2018-2034)
Figure 40. Asia Pacific Antihelminthics Revenue Market Share by Region (2018-2034)
Figure 41. China Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Japan Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. South Korea Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. India Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Australia Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Taiwan Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Indonesia Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Thailand Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Malaysia Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Philippines Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Latin America Antihelminthics Sales Market Share by Country (2018-2034)
Figure 52. Latin America Antihelminthics Revenue Market Share by Country (2018-2034)
Figure 53. Mexico Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Brazil Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Argentina Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Middle East & Africa Antihelminthics Sales Market Share by Country (2018-2034)
Figure 57. Middle East & Africa Antihelminthics Revenue Market Share by Country (2018-2034)
Figure 58. Turkey Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. Saudi Arabia Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 60. U.A.E Antihelminthics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 61. Global Sales Market Share of Antihelminthics by Type (2018-2034)
Figure 62. Global Revenue Market Share of Antihelminthics by Type (2018-2034)
Figure 63. Global Antihelminthics Price (USD/Unit) by Type (2018-2034)
Figure 64. Global Sales Market Share of Antihelminthics by Application (2018-2034)
Figure 65. Global Revenue Market Share of Antihelminthics by Application (2018-2034)
Figure 66. Global Antihelminthics Price (USD/Unit) by Application (2018-2034)
Figure 67. Antihelminthics Value Chain
Figure 68. Antihelminthics Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed